236 related articles for article (PubMed ID: 7541822)
1. Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR.
al-Ramadi BK; Jelonek MT; Boyd LF; Margulies DH; Bothwell AL
J Immunol; 1995 Jul; 155(2):662-73. PubMed ID: 7541822
[TBL] [Abstract][Full Text] [Related]
2. Localization of two cytotoxic T lymphocyte epitopes and three anchoring residues on a single nonameric peptide that binds to H-2Ld and is recognized by cytotoxic T lymphocytes against mouse tumor P815.
Van den Eynde B; Mazarguil H; Lethé B; Laval F; Gairin JE
Eur J Immunol; 1994 Nov; 24(11):2740-5. PubMed ID: 7525302
[TBL] [Abstract][Full Text] [Related]
3. Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.
Shier P; Ngo K; Fung-Leung WP
J Immunol; 1999 Nov; 163(9):4826-32. PubMed ID: 10528183
[TBL] [Abstract][Full Text] [Related]
4. Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomes.
Dutoit V; Guillaume P; Cerottini JC; Romero P; Valmori D
Eur J Immunol; 2002 Nov; 32(11):3285-93. PubMed ID: 12555674
[TBL] [Abstract][Full Text] [Related]
5. Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection.
Speiser DE; Kyburz D; Stübi U; Hengartner H; Zinkernagel RM
J Immunol; 1992 Aug; 149(3):972-80. PubMed ID: 1634779
[TBL] [Abstract][Full Text] [Related]
6. Development of a murine mutant Ras CD8+ CTL peptide epitope variant that possesses enhanced MHC class I binding and immunogenic properties.
Bristol JA; Schlom J; Abrams SI
J Immunol; 1998 Mar; 160(5):2433-41. PubMed ID: 9498787
[TBL] [Abstract][Full Text] [Related]
7. Comparison of phosphorylation and internalization of the antigen receptor/CD3 complex, CD8, and class I MHC-encoded proteins on T cells. Role of intracytoplasmic domains analyzed with hybrid CD8/class I molecules.
Boyer C; Auphan N; Gabert J; Blanc D; Malissen B; Schmitt-Verhulst AM
J Immunol; 1989 Sep; 143(6):1905-14. PubMed ID: 2506271
[TBL] [Abstract][Full Text] [Related]
8. A molecular basis for how a single TCR interfaces multiple ligands.
Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
[TBL] [Abstract][Full Text] [Related]
9. A residue in the center of peptide QL9 affects binding to both Ld and the T cell receptor.
Schlueter CJ; Manning TC; Schodin BA; Kranz DM
J Immunol; 1996 Nov; 157(10):4478-85. PubMed ID: 8906825
[TBL] [Abstract][Full Text] [Related]
10. Alterations in TCR-MHC contacts subsequent to cross-recognition of class I MHC and singly substituted peptide variants.
Ono T; DiLorenzo TP; Wang F; Kalergis AM; Nathenson SG
J Immunol; 1998 Nov; 161(10):5454-63. PubMed ID: 9820521
[TBL] [Abstract][Full Text] [Related]
11. Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses.
Kageyama S; Tsomides TJ; Sykulev Y; Eisen HN
J Immunol; 1995 Jan; 154(2):567-76. PubMed ID: 7814868
[TBL] [Abstract][Full Text] [Related]
12. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes.
Luescher IF; Vivier E; Layer A; Mahiou J; Godeau F; Malissen B; Romero P
Nature; 1995 Jan; 373(6512):353-6. PubMed ID: 7830771
[TBL] [Abstract][Full Text] [Related]
13. Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif.
Lipford GB; Hoffman M; Wagner H; Heeg K
J Immunol; 1993 Feb; 150(4):1212-22. PubMed ID: 7679422
[TBL] [Abstract][Full Text] [Related]
14. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis.
Christinck ER; Luscher MA; Barber BH; Williams DB
Nature; 1991 Jul; 352(6330):67-70. PubMed ID: 2062379
[TBL] [Abstract][Full Text] [Related]
15. Peptide affinity for MHC influences the phenotype of CD8(+) T cells primed in vivo.
Ma H; Kapp JA
Cell Immunol; 2001 Nov; 214(1):89-96. PubMed ID: 11902833
[TBL] [Abstract][Full Text] [Related]
16. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
17. Interactions between CD8alphabeta and the TCRalphabeta/CD3-receptor complex.
Rubin B; Riond J; Leghait J; Gairin JE
Scand J Immunol; 2006 Sep; 64(3):260-70. PubMed ID: 16918695
[TBL] [Abstract][Full Text] [Related]
18. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
Shirai M; Vacchio MS; Hodes RJ; Berzofsky JA
J Immunol; 1993 Aug; 151(4):2283-95. PubMed ID: 7688397
[TBL] [Abstract][Full Text] [Related]
19. Naturally occurring low affinity peptide/MHC class I ligands can mediate negative selection and T cell activation.
Motyka B; Teh HS
J Immunol; 1998 Jan; 160(1):77-86. PubMed ID: 9551958
[TBL] [Abstract][Full Text] [Related]
20. CTL escape viral variants. I. Generation and molecular characterization.
Lewicki H; Tishon A; Borrow P; Evans CF; Gairin JE; Hahn KM; Jewell DA; Wilson IA; Oldstone MB
Virology; 1995 Jun; 210(1):29-40. PubMed ID: 7793078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
